Armstrong Advisory Group, Inc
- SEC CIK
- 0001932952
- Latest filing
- Jul 13, 2026
CUE holding history
Cue Biopharma, Inc. in every 13F filed by Armstrong Advisory Group, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CUE overviewAll 13F holders of CUEFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −120−100.0% | Sold out | Holders |
| Q1 2026 | 120 | $28 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 120 | $37 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 120 | $87 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 120 | $82 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 120 | $131 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 120 | $131 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 120 | $91 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 120 | $149 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 120 | $317 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 120 | $317 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 120 | $276 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 120 | $438 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 120 | $429 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 120 | $342 | <0.1% | – | No prior filing | Holders |